Wang Minyan, Urenjak Jutta, Fedele Ernesto, Obrenovitch Tihomir P
Pharmacology, School of Pharmacy, University of Bradford, Bradford BD7 1DP, UK.
Biochem Pharmacol. 2004 Apr 15;67(8):1619-27. doi: 10.1016/j.bcp.2003.12.029.
Cortical spreading depression (CSD) is a temporary disruption of local ionic homeostasis that propagates slowly across the cerebral cortex, and may contribute to the pathophysiology of stroke and migraine. Previous studies demonstrated that nitric oxide (NO) formation promotes the repolarisation phase of CSD, and this effect may be cyclic GMP (cGMP)-mediated. Here, we have examined how phosphodiesterase (PDE) inhibition, either alone or superimposed on NO synthase (NOS) inhibition, alters CSD and the associated changes in extracellular cGMP. Microdialysis probes incorporating an electrode were implanted into the frontoparietal cortex of anaesthetised rats for quantitative recording of CSD, pharmacological manipulations, and dialysate sampling for cGMP measurements. CSD was induced by cathodal electrical stimulation in the region under study by microdialysis. Extracellular cGMP increased, but only slightly, during CSD. Perfusion of either zaprinast or sildenafil through the microdialysis probe, at concentrations that inhibited both PDE5 and PDE9 (and possibly other PDE), increased significantly extracellular cGMP. Unexpectedly, these levels remained high when NOS was subsequently inhibited with N(omega)-nitro-l-arginine methyl ester hydrochloride (l-NAME, 1mM). The most interesting pharmacological effect on CSD was obtained with sildenafil. This drug altered neither CSD nor the subsequent characteristic effect of NOS inhibition, i.e. a marked widening of CSD. The fact that NOS inhibition still widened CSD in the presence of the high extracellular levels of cGMP associated with PDE inhibition, suggests that NO may promote CSD recovery, independently of cGMP formation.
皮层扩散性抑制(CSD)是局部离子稳态的短暂破坏,它在大脑皮层中缓慢传播,可能与中风和偏头痛的病理生理学有关。先前的研究表明,一氧化氮(NO)的形成促进了CSD的复极化阶段,并且这种作用可能是由环磷酸鸟苷(cGMP)介导的。在这里,我们研究了磷酸二酯酶(PDE)抑制单独或叠加在一氧化氮合酶(NOS)抑制上如何改变CSD以及细胞外cGMP的相关变化。将带有电极的微透析探针植入麻醉大鼠的额顶叶皮层,用于定量记录CSD、进行药理学操作以及采集透析液以测量cGMP。通过微透析在研究区域进行阴极电刺激来诱导CSD。在CSD期间,细胞外cGMP有所增加,但幅度很小。通过微透析探针灌注扎普司特或西地那非,浓度达到抑制PDE5和PDE9(可能还有其他PDE)时,细胞外cGMP显著增加。出乎意料的是,随后用盐酸N(ω)-硝基-L-精氨酸甲酯(L-NAME,1mM)抑制NOS时,这些水平仍然很高。对CSD最有趣的药理学作用是西地那非产生的。这种药物既没有改变CSD,也没有改变随后NOS抑制的特征性作用,即CSD明显增宽。在与PDE抑制相关的高细胞外cGMP水平存在的情况下,NOS抑制仍然使CSD增宽,这一事实表明,NO可能独立于cGMP的形成促进CSD恢复。